Local Institution

San Luis Potosí City, San Luis Potosí 78240

0 studies enrolling now · 13 studies all time

What they study most

Acute Coronary Syndrome, Arthritis, Rheumatoid, Chronic Kidney Failure, Kidney Transplantation, Prostate Cancer, Pulmonary Embolism, Rheumatoid Arthritis, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus, Type 2 Diabetes, Venous Thrombosis

Studies at this site

• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) — Completed
• Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis — Completed
• Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness — Completed
• Methotrexate-Inadequate Response Study — Completed
• Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis — Completed
• Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Phase IIIB Switching From Intravenous to Subcutaneous Study — Completed
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Remission and Joint Damage Progression in Early Rheumatoid Arthritis — Completed